Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

for
Idiopathic Pulmonary Arterial Hypertension,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 15 - 70+

Code: NCT05584722

Recruiting

Repurposing Valsartan May Protect Against Pulmonary Hypertension

for
Pulmonary Arterial Hypertension, Right Heart Failure,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 70+

Code: NCT06053580

Phase 2, Recruiting

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

for
Pulmonary Arterial Hypertension
Location: Baltimore MD, Cleveland OH, Nashville TN
Sponsor: Gustavo A Heresi, MD, MS

Sex: All

Age: 18+

Code: NCT06992440

Phase 2, Recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

for
Pulmonary Arterial Hypertension
Location: New York NY, Philadelphia PA, Falls Church VA,
Sponsor: Gossamer Bio USA, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06274801

Phase 3, Recruiting

PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn

for
Persistent Pulmonary Hypertension of the Newborn
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 0 - 1

Code: NCT00710177

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PET Image in PAH Patients

for
Pulmonary Arterial Hypertension
Location: Pittsburgh PA
Sponsor: Stephen Y. Chan

Sex: All

Age: 18 - 70+

Code: NCT05452889

Early Phase 1, Recruiting

A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults

for
Pulmonary Arterial Hypertension
Location: Boston MA, Providence RI, Tampa FL
Sponsor: 35Pharma Inc., a GSK company

Sex: All

Age: 18+

Code: NCT07143448

Phase 1, Phase 2, Recruiting

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Location: Philadelphia PA, Tucson AZ
Sponsor: IRulya Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05798923

Phase 2, Recruiting

A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia

for
Hypertensive Disorder of Pregnancy,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18 - 45

Code: NCT07312227

Recruiting

Ventilator Pressure and Optimization of Compliance and Hemodynamics

for
Bronchopulmonary Dysplasia,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 0

Code: NCT06512935

Recruiting

A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension

for
Pulmonary Arterial Hypertension
Location: Boston MA
Sponsor: Gmax Biopharm LLC.

Sex: All

Age: 18 - 70+

Code: NCT04503733

Phase 1, Recruiting

Sildenafil in US Heart Failure Patients (SilHF-US)

for
Heart Failure, Pulmonary Hypertension
Location: Hartford CT
Sponsor: Hartford Hospital

Sex: All

Age: 18 - 70+

Code: NCT03460470

Phase 3, Recruiting

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

for
Healthy Volunteers, Pulmonary Arterial Hypertension
Location: Boston MA, Burlington MA, Richmond VA, Pittsburgh PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06649110

Phase 1, Phase 2, Recruiting

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

for
Pulmonary Arterial Hypertension (PAH),
Location: Philadelphia PA, Washington D.C. DC, Jacksonville FL,
Sponsor: AllRock Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07175038

Phase 2, Recruiting

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

for
Sarcoidosis, Pulmonary Hypertension
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18 - 70+

Code: NCT01467791

Recruiting

U-CHAMP: Urban Cardiovascular Health Assessment and Management Program

for
Cardiovascular Diseases, Hypertension, Hyperlipidemia,
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 70+

Code: NCT00626041

Recruiting

Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care

for
Hypertension, Hyperlipidemia, Hyperglycemia,
Location: Burlington
Sponsor: Caroline Medical Group

Sex: All

Age: 0+

Code: NCT00291824

Phase 1, Recruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

for
Coronary Disease, Heart Diseases, Cardiovascular Diseases,
Location: Washington D.C. DC, Charleston WV, Plano TX, Dallas TX
Sponsor: Teleflex

Sex: All

Age: 18 - 70+

Code: NCT07258290

Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Riverhead NY, Hartford CT, Holyoke MA,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

Nutritional Supplements on Blood Pressure 2008

for
Hypertension
Location: Chesterfield MO
Sponsor: Logan College of Chiropractic

Sex: All

Age: 20 - 70

Code: NCT00609570

Phase 1, Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial